BioSyent acquires Oral Science
Source: SeekingAlpha
2026-02-09 07:57:33 ET
More on BioSyent
- BioSyent Inc. (RX:CA) Q3 2025 Earnings Call Prepared Remarks Transcript
- BioSyent Inc. 2025 Q3 - Results - Earnings Call Presentation
- Seeking Alpha’s Quant Rating on BioSyent
- Historical earnings data for BioSyent
- Dividend scorecard for BioSyent
Read the full article on Seeking Alpha
For further details see:
BioSyent acquires Oral Science
Biosyent Inc
NASDAQ: BIOYF
BIOYF Trading
0.0% G/L:
$11.50 Last:
314 Volume:
$11.50 Open:
BIOYF Latest News
BIOYF Stock Data
$121,939,228
9,202,161
2.14%
2
N/A
Pharmaceuticals
Healthcare
CA
Mississauga
